110 related articles for article (PubMed ID: 8981331)
1. Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III.
Schulze B; Sasaki T; Costell M; Mann K; Timpl R
Matrix Biol; 1996 Nov; 15(5):349-57. PubMed ID: 8981331
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
3. Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif.
Schulze B; Mann K; Battistutta R; Wiedemann H; Timpl R
Eur J Biochem; 1995 Aug; 231(3):551-6. PubMed ID: 7649154
[TBL] [Abstract][Full Text] [Related]
4. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
Hopf M; Göhring W; Kohfeldt E; Yamada Y; Timpl R
Eur J Biochem; 1999 Feb; 259(3):917-25. PubMed ID: 10092882
[TBL] [Abstract][Full Text] [Related]
5. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
[TBL] [Abstract][Full Text] [Related]
6. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
Murdoch AD; Dodge GR; Cohen I; Tuan RS; Iozzo RV
J Biol Chem; 1992 Apr; 267(12):8544-57. PubMed ID: 1569102
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan.
Costell M; Sasaki T; Mann K; Yamada Y; Timpl R
FEBS Lett; 1996 Nov; 396(2-3):127-31. PubMed ID: 8914972
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
Hayashi K; Madri JA; Yurchenco PD
J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
[TBL] [Abstract][Full Text] [Related]
9. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
Friedrich MV; Schneider M; Timpl R; Baumgartner S
Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan.
Ettner N; Göhring W; Sasaki T; Mann K; Timpl R
FEBS Lett; 1998 Jul; 430(3):217-21. PubMed ID: 9688542
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
12. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
Noonan DM; Fulle A; Valente P; Cai S; Horigan E; Sasaki M; Yamada Y; Hassell JR
J Biol Chem; 1991 Dec; 266(34):22939-47. PubMed ID: 1744087
[TBL] [Abstract][Full Text] [Related]
13. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycosaminoglycan modification of perlecan domain I by site-directed mutagenesis changes protease sensitivity and laminin-1 binding activity.
Sasaki T; Costell M; Mann K; Timpl R
FEBS Lett; 1998 Sep; 435(2-3):169-72. PubMed ID: 9762901
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of the globular domain IVa of the laminin alpha 1 chain and its impact on an adjacent RGD site.
Schulze B; Mann K; Poschl E; Yamada Y; Timpl R
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):847-51. PubMed ID: 8615779
[TBL] [Abstract][Full Text] [Related]
16. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
Talts JF; Andac Z; Göhring W; Brancaccio A; Timpl R
EMBO J; 1999 Feb; 18(4):863-70. PubMed ID: 10022829
[TBL] [Abstract][Full Text] [Related]
17. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
18. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.
Dolan M; Horchar T; Rigatti B; Hassell JR
J Biol Chem; 1997 Feb; 272(7):4316-22. PubMed ID: 9020150
[TBL] [Abstract][Full Text] [Related]
19. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence.
Chakravarti S; Horchar T; Jefferson B; Laurie GW; Hassell JR
J Biol Chem; 1995 Jan; 270(1):404-9. PubMed ID: 7814401
[TBL] [Abstract][Full Text] [Related]
20. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc.
Reinhardt D; Mann K; Nischt R; Fox JW; Chu ML; Krieg T; Timpl R
J Biol Chem; 1993 May; 268(15):10881-7. PubMed ID: 8496153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
